Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kirsty R Erickson"'
Autor:
Kirsty R Erickson, Rebekah Farmer, Jonathan K Merritt, Zeljka Miletic Lanaghan, Mark D Does, Karthik Ramadass, Bennett A Landman, Laurie E Cutting, Jeffrey L Neul
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0266861 (2022)
FOXG1 Syndrome (FS) is a devastating neurodevelopmental disorder that is caused by a heterozygous loss-of-function (LOF) mutation of the FOXG1 gene, which encodes a transcriptional regulator important for telencephalic brain development. People with
Externí odkaz:
https://doaj.org/article/7448f845799f409f93ef3af1df3c0bf8
Autor:
Zahra Z. Farahbakhsh, Keaton Song, Hannah E. Branthwaite, Kirsty R. Erickson, Snigdha Mukerjee, Suzanne O. Nolan, Cody A. Siciliano
Publikováno v:
Neuropsychopharmacology. 48:857-868
Selective inhibition of kappa opioid receptors (KORs) is highly anticipated as a pharmacotherapeutic intervention for substance use disorders and depression. The accepted explanation for KOR antagonist-induced amelioration of aberrant behaviors posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8349904caafb95145084ed98d957477b
https://doi.org/10.1038/s41386-023-01547-x
https://doi.org/10.1038/s41386-023-01547-x
Autor:
Kirsty R. Erickson, Rebekah Lifer, Jonathan K. Merritt, Zeljka Miletic Lanaghan, Mark D. Does, Karthik Ramadass, Bennett A. Landman, Laurie E. Cutting, Jeffrey L. Neul
FOXG1 Syndrome (FS) is a devastating neurodevelopmental disorder that is caused by a heterozygous loss-of-function (LOF) mutation of the FOXG1 gene, which encodes a transcriptional regulator important for telencephalic brain development. People with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d408a73ed2e9b4a4967836a5afe1030a
https://doi.org/10.1101/2022.03.29.486318
https://doi.org/10.1101/2022.03.29.486318
Publikováno v:
Genes Brain Behav
Rett syndrome is a neurodevelopmental disorder caused predominantly by loss-of-function mutations in MECP2, encoding transcriptional modulator methyl-CpG-binding protein 2 (MeCP2). Though no disease-modifying therapies exist at this time, some propos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd4c501eaa53f7dff11cb52ca5a2434d
https://europepmc.org/articles/PMC8563491/
https://europepmc.org/articles/PMC8563491/
Publikováno v:
Hum Mol Genet
Rett syndrome (RTT) is a neurodevelopmental disorder primarily caused by mutations in Methyl-CpG-binding Protein 2 (MECP2). More than 35% of affected individuals have nonsense mutations in MECP2. For these individuals, nonsense suppression has been s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d922d2b6fdbed65bade1ff77fbcfe5e2
https://pubmed.ncbi.nlm.nih.gov/32469049
https://pubmed.ncbi.nlm.nih.gov/32469049
Autor:
Hong-Wei Dong, Jessica R. Lee, Kirsty R Erickson, Jeffrey L. Neul, Jonathan K. Merritt, Cary Fu
Publikováno v:
Neurobiology of disease
Neurobiology of Disease, Vol 145, Iss, Pp 105083-(2020)
Neurobiology of Disease, Vol 145, Iss, Pp 105083-(2020)
Rett syndrome (RTT) is a severe neurodevelopmental disorder (NDD) that is nearly always caused by loss of function mutations in Methyl-CpG-binding Protein 2 (MECP2) and shares many clinical features with other NDD. Genetic restoration of Mecp2 in sym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcf80aa2017d4e5965960293abd9d00e
http://europepmc.org/articles/PMC7572861
http://europepmc.org/articles/PMC7572861